Latest Commercial Agreements News

Zinc of Ireland has secured firm commitments for a $3.2 million placement to fund ARGO critical-mineral recovery work, VOLTA battery-recycling development and drilling at Kildare. The raise gives the company a defined execution schedule, but adds 180 million new shares before several commercial milestones remain unproven.

Ovanti has reported a A$23.61 million FY2026 loss, A$21.27 million in operating cash outflows and only A$291,867 in cash at year end. The ASX-listed fintech has abandoned BNPL globally, but says its continuing operations and proposed funding initiatives provide a basis to keep trading despite a material going-concern uncertainty.

An independent transport study has found Alurion Resources’ Amargosa bauxite project can use established road routes for assessed haulage volumes up to 11.5 wet million tonnes a year, twice its Scoping Study base case. The result gives the project’s pre-feasibility study a firmer logistics foundation, although it does not establish a larger production target or guarantee port access.

LTR Pharma has completed the final Phase II pharmacokinetic report for SPONTAN, confirming a median 10-minute time to peak concentration against 60 minutes for an oral vardenafil tablet. The result completes the FDA-aligned dataset ahead of planned US submission work, although efficacy in erectile dysfunction patients remains to be tested.

CONNEQT Health delivered sharp FY26 revenue growth and reduced its statutory loss as Pulse sales and clinical subscriptions expanded. But the ASX-listed medtech group ended the year with negative net assets, heavy cash burn and a material uncertainty over its ability to continue as a going concern.

1414 Degrees reported a wider FY2026 loss, falling cash reserves and a material uncertainty over its ability to continue as a going concern. The company is nevertheless pressing ahead with SiNTL battery commercialisation, a proposed 1 GW data centre precinct and full ownership of Aurora.

Firebird Metals is moving from manganese exploration towards downstream battery materials, with its Perth demonstration plant backed by a A$2 million ARENA grant. But the ASX-listed company remains loss-making, has A$3.61 million in cash and faces a material uncertainty over its ability to continue without further funding.

First Graphene expanded its product range and international footprint in FY2026, lifting revenue while narrowing its annual loss. But the company says continued operations depend on securing further equity funding, putting commercial execution and liquidity at the centre of its next phase.

Nico Resources is advancing drilling, metallurgical studies and a potential downstream battery-materials partnership at Wingellina, despite a subdued nickel market and a larger annual loss. The company ended FY2026 with $4.73 million across cash and short-term investments after raising $3.73 million in equity.

EcoGraf has strengthened the technical and commercial case for its Tanzanian graphite strategy, including a larger Epanko ore reserve and planned downstream processing. But cash fell to A$3.8 million, and auditors flagged a material uncertainty over the company’s ability to continue as a going concern.

Cobalt Blue has cleared important technical and regulatory hurdles at its Kwinana refinery, but the pre-revenue developer says further funding is needed and auditors flagged material uncertainty over its ability to continue as a going concern. The company reported an A$8.797 million loss for FY2026 despite ending the year with A$4.265 million in cash.

4DMedical delivered sharp growth in scans, sites and operating revenue as CT:VQ moved into commercial deployment across several global markets. But the company remains loss-making and its auditor issued a qualified opinion over the carrying value of goodwill and other intangible assets.